How autonomous AI agents will change cancer research
Published in Nature Cancer: researchers from EKFZ and Genentech explain how autonomous AI models will change workflows in cancer research.
Read moreAI in Medicine – Bridging bytes and bedside
A networking event together with the Saxon State Chancellery
Prof. Kather and the Clinical AI research group at Else Kröner Fresenius Center for Digital Health in cooperation with the Saxon State Chancellery brought together 150 participants for a networking event about AI in medicine.
Chief of the State Chancellery and State Minister Oliver Schenk opened the event pointing out that Saxony has a powerful, technology-related and application-oriented research landscape. And that the Free State of Saxony continues to consistently expand the excellent research structures in the Free State in the area of AI and open them up to the latest developments.
Various speakers gave interesting insights into AI in medicine:
⭐ An entertaining ScienceSlam on AI in Histopathology by Marco Gustav and Chiara M. L. Loeffler
⭐ Insights into the Health Data Act of the Bundesministerium für Gesundheit by Malte Schmieding
⭐ Possibilities and Challenges of LLMs in Medicine presented by Stephen Gilbert.
⭐ An inspiring keynote by Jens Kleesiek on integrating AI into the Universitätsmedizin Essen
The participants could connect with different start-ups and research projects taking a closer look on use cases of AI in medicine. Many thanks for demonstrating at our event: Falk Zakrzewski from Katana Labs, Moritz Middeke from Cancilico, Florian Schier and Daniel Badeja from the VRAD project and futureSAX.
A large community around digital health and AI in medicine has grown in Dresden and Saxony. We are proud to be part of it! Our vision is to bring together the expertise of medical professionals and high-tech specialists to create ideal framework conditions for promising medical research to make the future of healthcare personalized, preventive and predictive.
